Drugs: Consider the probable side effects

Journal of Dementia Care

Volumn 13, Issue 2, 2005, Pages 33-35

  Iliffe, Steve ^a   Manthorpe, Jill ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DONEPEZIL; GALANTAMINE; MEMANTINE; NOOTROPIC AGENT; RIVASTIGMINE;

AGING; ARTICLE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DEMENTIA; DISEASE SEVERITY; DRUG INDUSTRY; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE NEED; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH ECONOMICS; HUMAN; MEDICAL DECISION MAKING; NATIONAL HEALTH SERVICE; PHARMACEUTICAL CARE; POLITICS; PRACTICE GUIDELINE; PRESCRIPTION; PUBLIC HEALTH SERVICE;

EID: 15344349307     PISSN: 13518372     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)